Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Introduction to Efavir-600
Efavir-600, containing the active ingredient Efavirenz, is an antiretroviral medication used in the management of Human Immunodeficiency Virus (HIV) infection. Each tablet contains 600 mg of Efavirenz, which is part of the non-nucleoside reverse transcriptase inhibitors (NNRTIs) class of drugs.
Uses of Efavir-600
Efavir-600 is primarily used in combination with other antiretroviral agents for the treatment of HIV-1 infection. It helps to reduce the amount of HIV in the body, thereby improving the immune system function and reducing the risk of HIV-related complications.
Benefits of Efavir-600
Effective HIV Management: Efavirenz, the active component, is potent in reducing viral load in HIV-infected patients.
Once-Daily Dosing: The 600 mg dosage allows for convenient once-daily administration.
Combination Therapy: Efavirenz is often used as part of a combination antiretroviral therapy (cART) regimen, enhancing overall treatment efficacy.